Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer
Introduction
Links between cancer and inflammation were first suggested in the 19th century on the basis of observations that tumors often arise at sites of chronic inflammation and that inflammatory cells are present in the biopsied samples from tumors (Mantovani et al., 2001). Epidemiological studies have shown that chronic inflammation predisposes individuals to various types of cancer, including microbial infections, autoimmune diseases, and inflammatory conditions of unknown origin. The hallmarks of cancer‐related inflammation include the presence in tumor tissues of inflammatory cells and soluble mediators such as chemokines, cytokines and prostaglandins, tissue remodeling, and angiogenesis (Coussens and Werb, 2002, Karin, 2006, Mantovani, 2005, Mantovani et al., 2008).
Chemokines are chemotactic cytokines that cause the direct migration of leukocytes and are induced by inflammatory cytokines, growth factors, and pathogenic stimuli. Many human cancers have a complex chemokine network that regulates the extent and phenotype of the infiltrating leukocytes, as well as have an effect on tumor growth, survival, migration, and angiogenesis (Balkwill, 2004). The pattern of chemokine‐receptor and ligand expression in a tissue is generally correlated with the numbers and types of infiltrating cells that are present in the tumor microenvironment (Balkwill, 2004, Karin and Greten, 2005, Rossi and Zlotnik, 2000).
The influence of the immune response in the behavior of neoplasia has been extensively investigated. There is little doubt that adaptive immune cells, especially cytotoxic CD8+ T‐cell effectors, have the potential to limit tumor progression (Dunn et al., 2004). The protective function of CD8+ T cells has been demonstrated in patients with melanoma, ovarian, and colorectal cancer (CRC) (Coukos et al., 2005, Taylor et al., 2007). Recently, Galon and colleagues (Galon et al., 2006, Pages et al., 2005) demonstrated that the presence of a strong immune‐cell infiltrate is associated with the absence of early metastatic processes, which include vascular emboli, lymphatic invasion, and perineural invasion, demonstrating a beneficial effect of the host's immune response.
On the other hand, the persistence of active innate immune responses (i.e., chronic inflammation) at tumor sites has been more frequently associated with poor clinical outcome (Balkwill, 2004, Coussens and Werb, 2002, Dunn et al., 2004, Karin, 2006, Mantovani, 2005, Mantovani et al., 2001, Mantovani et al., 2008).
The links between inflammation and cancer promotion are especially strong in human colorectal carcinoma (CRC), the second largest cause of cancer‐related death in Western countries. Patients with inflammatory bowel disease, both ulcerative colitis and Crohn's disease, are at increased risk of developing colorectal cancer. Even precancerous tissues show signs of inflammation. Accordingly, treatment with nonsteroidal anti‐inflammatory agents decreases the incidence of colon cancer, and the mortality that results from it (Bertagnolli, 2003).
The contribution of macrophages to CRC development is quite controversial. Bailey et al. (2007) demonstrated that the increase of macrophages number in all areas within the tumor correlated with advanced tumor stage. In contrast, Forssell et al. (2007) showed that in CRC, macrophages are localized principally at the tumor front and positively influenced prognosis. These contrasting results may be explained by the “macrophages balance hypothesis,” proposed by our group, to convey the idea that macrophages may inhibit or stimulate tumor growth according to their functional polarization and state of activation (Mantovani et al., 2004, Mantovani et al., 2002, Pollard, 2004). While M1‐polarized macrophages, activated by IFNγ and bacterial products such as LPS, usually have tumoricidal activity, M2 macrophages, differentiated in the presence of Th2 cytokines (IL‐4, IL‐13) or IL‐10, most frequently are not cytotoxic, favor tumor cell proliferation and the angiogenic switch, and lead to tumor progression and invasion (Mantovani et al., 2008). In this context, it is clear that inflammatory mediators, such as chemokines, cytokines, and growth factors play a pivotal role in the recruitment of the inflammatory infiltrate and in the buildup of the tumor microenvironment.
In this study, we investigated the expression of chemokines and chemokine‐receptors in surgical samples of human CRC. We analyzed the mRNA profile using a customized TaqMan Low Density Array (Lu et al., 2008). The results show a strong upregulation of chemokines and chemokine‐receptors, indicating the pivotal role of these inflammatory mediators in the growth and progression of CRC.
Section snippets
Cell culture and tissue collection and processing
Thirty colon cancer samples and corresponding normal tissues were obtained via surgical resection from the Department of Gastroenterology, Istituto Clinico Humanitas IRCCS, Rozzano, Milan. The samples were immediately treated with RNAlater (Ambion) for 24 h at 4°, and subsequently dried and stored at −80°. All patients consented to the study. CRC cell lines HCT116, HT29, and SW620 were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (Lonza, BioWhittaker), 2 mM
TaqMan Low Density Array analysis of eight colon cancer samples
To investigate the role of chemokines and their receptors in colon cancer tissues, we performed a large screening of inflammation‐related genes in eight human colon cancer samples and corresponding normal tissues, using the TaqMan Low Density Array (Applied Biosystem), customized with 91 inflammation‐related genes, selected by us, and 5 housekeeping genes. Among the 91 inflammation‐related genes, 24 were chemokines and 17 were chemokine‐receptors. Table 5.1 shows an overview of the results from
Discussion
In this study, we have investigated the chemokine system in samples of human colorectal tumors. To obtain a global view of which chemokines and receptors are overexpressed in the tumor microenvironment, we have used a customized TaqMan Low Density Array containing probes for 24 ligands and 17 receptors. Several CC and CXC chemokines were strongly upregulated in tumor samples compared to the paired normal colonic mucosa. Interestingly, a number of chemokines were constitutively expressed also in
Acknowledgments
This work was supported by the Italian Association for Cancer Research (AIRC), MIUR target project Oncologia 2006, and Alleanza Contro il Cancro.
References (37)
- et al.
TaqMan low density array is roughly right for gene expression quantification in colorectal cancer
Clin. Chim. Acta
(2008) - et al.
The chemokine system in diverse forms of macrophage activation and polarization
Trends Immunol.
(2004) - et al.
Macrophage polarization: Tumor‐associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends Immunol.
(2002) - et al.
Systemic endocrine instigation of indolent tumor growth requires osteopontin
Cell
(2008) - et al.
Cancer CXC chemokine networks and tumour angiogenesis
Eur. J. Cancer
(2006) - et al.
The yin‐yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Immunol. Rev.
(2008) - et al.
Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer
Clin. Exp. Metastasis
(2007) Cancer and the chemokine network
Nat. Rev. Cancer
(2004)- et al.
Small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs): Multifunctional proteins in cancer
Nat. Rev. Cancer
(2008) The potential of non‐steroidal anti‐inflammatory drugs (NSAIDs) for colorectal cancer prevention
J. Surg. Oncol.
(2003)
Osteopontin and interleukin‐8 expression is independently associated with prostate cancer recurrence
Clin. Cancer Res.
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix
Int. J. Cancer
A prototypic matricellular protein in the tumor microenvironment—where there's SPARC, there's fire
J. Cell Biochem.
Immunotherapy for gynaecological malignancies
Expert Opin. Biol. Ther.
Inflammation and cancer
Nature
Thresholds for Cenozoic bipolar glaciation
Nature
The three Es of cancer immunoediting
Annu. Rev. Immunol.
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer
Clin. Cancer Res.
Cited by (88)
Chronic inflammation and cancer; the two sides of a coin
2024, Life SciencesSingle-molecule and super-resolved imaging deciphers membrane behavior of onco-immunogenic CCR5
2022, iScienceCitation Excerpt :Despite this immunogenic feature of the CCR5-CCL5 axis, cancer cells are capable of “educating” migrating immune cells to form an immunosuppressive tumor microenvironment.5,6,7 Further, oncogenic transformation of cells has been shown to increase the surface expression of CCR5.8,9,10,11 As a result, CCR5 has become a strong point of investigation in studies relating to both immunology and cancer.